1-17 of 17
Pamela Drullinsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

Robert Stuver, Laure Michaud, Carla Casulo, Ranjana H. Advani, Elizabeth L. Budde, Paul M. Barr, Connie Lee Batlevi, Philip C Caron, Louis S. Constine, Savita Dandapani, Pamela Drullinsky, Jonathan W. Friedberg, Clare Grieve, Audrey Hamilton, Paul A. Hamlin, Richard Hoppe, Steven M. Horwitz, Niloufer Khan, Matthew J. Matasar, Ariela Noy, M.Lia Palomba, Heiko Schoder, David J. Straus, Shreya Vemuri, Joachim Yahalom, Joanna C. Yang, Anas Younes, Andrew D. Zelenetz, Craig H. Moskowitz, Anita Kumar, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 1756–1758.
https://doi.org/10.1182/blood-2022-156382
Published: 2022
Journal Articles

Frontline Sequential Immunochemotherapy Plus Lenalidomide for Mantle Cell Lymphoma Incorporating MRD Evaluation: Phase II, Investigator-Initiated, Single-Center Study

Zachary D. Epstein-Peterson, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Ahmet Dogan, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Caleb Ho, MD, Allison P. Jacob, Leana Laraque, BA, Matthew J Matasar, MD, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Colette Owens, MD, Gilles Salles, Heiko Schöder, MD, David J. Straus, MD, Anas Younes, Andrew D Zelenetz, MD PhD, Anita Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136565
Published: 2020
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, Ranjana H Advani, MD, Lihua E Budde, MD PhD, Paul M. Barr, MD, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Louis S. Constine, MD, Savita Dandapani, MD PhD, Esther Drill, PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, Clare Grieve, BA, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T Hoppe, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Heiko Schoder, MD, David J. Straus, MD, Shreya Vemuri, Joanna C Yang, MD MPH, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2834.
https://doi.org/10.1182/blood-2019-123150
Published: 2019
Journal Articles

A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma

Niloufer Khan, MD, Andrei R Shustov, MD, Farhad Khimani, MD, Mazyar Shadman, MD, Ryan D. Cassaday, MD, Jia Ruan, MD PhD, Alison J. Moskowitz, MD, Andrew D. Zelenetz, MD PhD, Ariela Noy, MD, David J. Straus, MD, Pamela Drullinsky, MD, Audrey Hamilton, MD, Anita Kumar, MD, Craig S. Sauter, MD, Gunjan L. Shah, MDMS, Matthew J Matasar, MD, Esther Drill, PhD, Theresa Davey, MMSc, PA-C, Helen Hancock, ANP, Alexandra Bahgat, BS, William Blouin, MBA, Karen Marie Schiavo, BSN,MS,NP, Heather Smith, PA-C, Koen Van Besien, MD PhD, Sergio A. Giralt, MD, Steven M. Horwitz, MD, Parastoo B. Dahi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4033.
https://doi.org/10.1182/blood-2019-124179
Published: 2019
Journal Articles

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

Clinical Trials & Observations
Sven Borchmann, Erel Joffe, Craig H. Moskowitz, Andrew D. Zelenetz, Ariela Noy, Carol S. Portlock, John F. Gerecitano, Connie L. Batlevi, Philip C. Caron, Pamela Drullinsky, Audrey Hamilton, Paul A. Hamlin, Jr, Steven M. Horwitz, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Colette N. Owens, M. Lia Palomba, Anas Younes, David J. Straus
Journal: Blood
Blood (2019) 133 (20): 2121–2129.
https://doi.org/10.1182/blood-2018-10-877761
Published: 2019
Includes: Supplemental data
Journal Articles

Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Anita Kumar, MD, Andrew D. Zelenetz, MD PhD, Connie Lee Batlevi, MD, Philip Caron, MD PhD, Ahmet Dogan, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Leana Laraque, BA, Matthew J Matasar, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Colette Owens, MD, Janine Pichardo, Heiko Schoder, MD, Allison Sigler, David J. Straus, MD, Anas Younes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2880.
https://doi.org/10.1182/blood-2018-99-120069
Published: 2018
Journal Articles

A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL

Clinical Trials & Observations Brief Report
Craig S. Sauter, Matthew J. Matasar, Heiko Schoder, Sean M. Devlin, Pamela Drullinsky, John Gerecitano, Anita Kumar, Ariela Noy, Maria L. Palomba, Carol S. Portlock, David J. Straus, Andrew D. Zelenetz, Susan J. McCall, Shoshana T. Miller, Amanda I. Courtien, Anas Younes, Craig H. Moskowitz
Journal: Blood
Blood (2018) 131 (16): 1805–1808.
https://doi.org/10.1182/blood-2017-08-802561
Published: 2018
Includes: Supplemental data
Journal Articles

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, MD, Ranjana H. Advani, MD, Lihua Budde, MD PhD, Paul M. Barr, MD, Connie L. Batlevi, MD PhD, Philip Caron, MD PhD, Robert W. Chen, MD, Louis S. Constine, MD, Amanda Courtien, Savita Dandapani, MD PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T. Hoppe, MD, Steven M. Horwitz, MD, Matthew J. Matasar, MD, Shoshana T. Miller, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria L. Palomba, MD, Carol S. Portlock, MD, Heiko Schoder, MD, David J. Straus, MD, Joanna C. Yang, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Joachim Yahalom, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 734.
https://doi.org/10.1182/blood.V130.Suppl_1.734.734
Published: 2017
Journal Articles

Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Sven Borchmann, Erel Joffe, MDMSc, Craig H. Moskowitz, MD, Andrew D. Zelenetz, MD PhD, Ariela Noy, MD PhD, Carol S Portlock, MD, John F Gerecitano, MD PhD, Connie Batlevi, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Colette N Owens, MD BA, Lia Palomba, MD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 654.
https://doi.org/10.1182/blood.V130.Suppl_1.654.654
Published: 2017
Journal Articles

Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis

Anna Alperovich, MD, Connie L. Batlevi, MD PhD, Andrew M Intlekofer, MD PhD, Craig H. Moskowitz, MD, Steven M. Horwitz, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Palomba, MD, Alison J. Moskowitz, MD, John Gerecitano, MD PhD, Paul A. Hamlin, MD, Matthew J. Matasar, MD, Craig S. Sauter, MD, Anita Kumar, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, Audrey Hamilton, MD, Pamela Drullinsky, MD, Philip Caron, MD PhD, Ai Ni, PhD, Venkatraman Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1494.
https://doi.org/10.1182/blood.V130.Suppl_1.1494.1494
Published: 2017
Journal Articles

Intervention Versus Observation: What Is the Appropriate Endpoint? Assessment of Endpoints in Patients with Advanced Stage Follicular Lymphoma Who Are Initially Observed

Jacob D Soumerai, MD, Kurt S Bantilan, MPH, Ai Ni, PhD, Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Amanda R Copeland, RN, MSN, CNS, Matthew J. Matasar, MD MS, David J Straus, MD, John F Gerecitano, MD PhD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Carol S Portlock, MD, Maria Lia Palomba, MD, Craig H Moskowitz, MD, Alison J Moskowitz, MD, Ariela Noy, MD PhD, Craig S Sauter, MD, Anita Kumar, MD, Andrew M Intlekofer, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Anas Younes, MD, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1777.
https://doi.org/10.1182/blood.V128.22.1777.1777
Published: 2016
Journal Articles

Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

Anna Alperovich, MD, Connie Batlevi, MD PhD, Katy Smith, MBBS, MRCP, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MDMSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 2955.
https://doi.org/10.1182/blood.V128.22.2955.2955
Published: 2016
Journal Articles

Outcomes of Follicular Lymphoma Patients By Dynamic FLIPI at Diagnosis and Initial Treatment in the Post-Rituximab Era

Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MD MSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 4119.
https://doi.org/10.1182/blood.V128.22.4119.4119
Published: 2016
Journal Articles

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

Clinical Trials & Observations
Anita Kumar, Carla Casulo, Joachim Yahalom, Heiko Schöder, Paul M. Barr, Philip Caron, April Chiu, Louis S. Constine, Pamela Drullinsky, Jonathan W. Friedberg, John F. Gerecitano, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Alexandra G. Jacob, Matthew J. Matasar, Gianna N. McArthur, Susan J. McCall, Alison J. Moskowitz, Ariela Noy, Maria L. Palomba, Carol S. Portlock, David J. Straus, Nicholas VanderEls, Stephanie L. Verwys, Joanna Yang, Anas Younes, Andrew D. Zelenetz, Zhigang Zhang, Craig H. Moskowitz
Journal: Blood
Blood (2016) 128 (11): 1458–1464.
https://doi.org/10.1182/blood-2016-03-703470
Published: 2016
Includes: Supplemental data
Journal Articles

Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Joachim Yahalom, MD, Heiko Schoder, MD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F. Gerecitano, MD PhD, Audrey Hamilton, MD, Paul Hamlin, MD, Steven M. Horwitz, MD, Alexandra G. Jacob, BS, Matthew J. Matasar, MD MS, Susan McCall, Alison J Moskowitz, MD, Ariela Noy, Lia Palomba, MD, Carol S Portlock, MD, David J. Straus, MD, Stephanie Verwys, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Anas Younes, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2014) 124 (21): 3085.
https://doi.org/10.1182/blood.V124.21.3085.3085
Published: 2014
Journal Articles

Ofatumumab-Bendamustine As First Line Treatment for Elderly Patients with Mantle Cell Lymphoma: A Phase II Risk Adapted Design with Comprehensive Geriatric Assessment

Carla Casulo, MD, Augustine Iannotta, BS, Jannelle Walkley, BS, Craig H. Moskowitz, MD, Alison J Moskowitz, MD, Pamela Drullinsky, MD, Andrew D. Zelenetz, MD PhD, Paul Hamlin, MD
Journal: Blood
Blood (2014) 124 (21): 1751.
https://doi.org/10.1182/blood.V124.21.1751.1751
Published: 2014